Dynamic Properties of an Inositol 1,4,5-Trisphosphate– and Thapsigargin-insensitive Calcium Pool in Mammalian Cell Lines

The functional characteristics of a nonacidic, inositol 1,4,5-trisphosphate– and thapsigargin-insensitive Ca²⁺ pool have been characterized in mammalian cells derived from the rat pituitary gland (GH3, GC, and GH3B6), the adrenal tissue (PC12), and mast cells (RBL-1). This Ca²⁺ pool is released into the cytoplasm by the Ca²⁺ ionophores ionomycin or A23187 after the discharge of the inositol 1,4,5-trisphosphate–sensitive store with an agonist coupled to phospholipase C activation and/or thapsigargin. The amount of Ca²⁺ trapped within this pool increased significantly after a prolonged elevation of intracellular Ca²⁺ concentration elicited by activation of Ca²⁺ influx. This pool was affected neither by caffeine-ryanodine nor by mitochondrial uncouplers. Probing mitochondrial Ca²⁺ with recombinant aequorin confirmed that this pool did not coincide with mitochondria, whereas its homogeneous distribution across the cytosol, as revealed by confocal microscopy, and its insensitivity to brefeldin A make localization within the Golgi complex unlikely. A proton gradient as the driving mechanism for Ca²⁺ uptake was excluded since ionomycin is inefficient in releasing Ca²⁺ from acidic pools and Ca²⁺ accumulation/release in/from this store was unaffected by monensin or NH₄Cl, drugs known to collapse organelle acidic pH gradients. Ca²⁺ sequestration inside this pool, thus, may occur through a low-affinity, high-capacity Ca²⁺–ATPase system, which is, however, distinct from classical endosarcoplasmic reticulum Ca²⁺–ATPases. The cytological nature and functional role of this Ca²⁺ storage compartment are discussed.The cytosolic free Ca²⁺ concentration ([Ca²⁺]_i)¹ of eukaryotic cells rests in the range of 50–200 nM, i.e., at a very low level, if compared to the Ca²⁺ concentration of physiological media (2 mM). However, the total cellular Ca²⁺ content is closer to this latter value (1–3 mmol/l of cell water). In other words, eukaryotic cells sequester large amounts of Ca²⁺ mainly by uptake inside intracellular Ca²⁺ stores (∼90%) (for reviews see Pozzan et al., 1994; Clapham, 1995).The complexity of intracellular Ca²⁺ stores has been intensively investigated in recent years (for reviews see Meldolesi et al., 1990; Pozzan et al., 1994; Simpson et al., 1995). Attention has been focused mainly on Ca²⁺ stores that are highly dynamic because of their ability to rapidly take up and release Ca²⁺. Ca²⁺ sequestration into these pools depends on Ca²⁺–ATPases, known as sarco/endoplasmic reticulum Ca²⁺–ATPases (SERCAs) (Burk et al., 1989; Bobe et al., 1994; Wuytack et al., 1994). All the SERCA isoforms share the property of being selectively inhibited by thapsigargin (Tg), a tumor-promoting sesquiterpene lactone (Lytton et al., 1991). Tg acts with both high affinity, at nanomolar concentrations, and high specificity, with virtually no effect on the Ca²⁺– or Na⁺/K⁺– ATPase of the plasmalemma.Other drugs, such as 2,5-di(tert-butyl)-1,4-benzohydroquinone (tBHQ) and cyclopiazonic acid (CA), also block SERCAs, albeit with a significantly lower affinity (Mason et al., 1991). Ca²⁺ release, on the other hand, depends mainly on two types of Ca²⁺ release channels named inositol 1,4,5-trisphosphate (InsP₃) and ryanodine receptors (for reviews see Mikoshiba, 1993; Sorrentino and Volpe, 1993; Ehrlich, 1995). These channels are expressed in variable proportions in different cell types and couple extracellular stimuli to the release of Ca²⁺, with possible ensuing generation of Ca²⁺ waves and spikes (for reviews see Amundson and Clapham, 1993; Taylor, 1994; Bootman and Berridge, 1995). The relationship between these types of Ca²⁺-release channels is still largely debated. The ryanodine-sensitive channel is also activated by caffeine, and ryanodine- and caffeine-sensitive stores are generally regarded to comprise the same pool (Zacchetti et al., 1991; Barry and Cheek, 1994; but also see Giannini et al., 1992; McNulty and Taylor, 1993).In the vast majority of cell types so far investigated, the InsP₃- (and/or the ryanodine-) sensitive stores almost completely overlap with those sensitive to Tg (Zacchetti et al., 1991; Gamberucci et al., 1995) and are thus referred to also as Tg-sensitive Ca²⁺ pools. From the cytological point of view, the InsP₃-/Tg-sensitive Ca²⁺ pool is identified with the ER or with a subfraction of it (Hashimoto et al., 1988).The complexity of the relationships between the InsP₃- and ryanodine/caffeine-sensitive stores does not cover the entire issue of intracellular Ca²⁺ pool heterogeneity. Other types of Ca²⁺ pools are known to exist, the size of which varies considerably among different cell types. These latter Ca²⁺ stores account for roughly half of all sequestered Ca²⁺ (Chandra et al., 1991; Fasolato et al., 1991; Shorte et al., 1991; Bastianutto et al., 1995; Mery et al., 1996). They have been identified through the increase in [Ca²⁺]_i upon application of Ca²⁺ ionophores, after depletion of the Tgsensitive pool with a combination, or a sequence, of InsP₃generating agonists, Tg, and caffeine. These residual Tginsensitive pools appear rather heterogeneous in terms of cytological identity and pharmacological sensitivity. Part of these pools shows an acidic lumenal pH and is discharged only by a combination of a Ca²⁺ ionophore and of agents that collapse internal acidic pH gradients (such as monensin and NH₄Cl). ⁴⁵Ca²⁺ labeling of Tg-insensitive pools is slower than that of the Tg-sensitive store, and, for this reason, they have been generally indicated as slowly exchanging Ca²⁺ pools (Fasolato et al., 1991). As far as their identification is concerned, the acidic pool seems largely identifiable with secretory compartments and lysosomes, while very little is known yet about the rest of the Tg-insensitive store.Here we demonstrate that a nonacidic, InsP₃- and Tg- insensitive Ca²⁺ pool rapidly accumulates large amounts of Ca²⁺ when high and sustained increases of [Ca²⁺]_i are induced by opening of voltage- or store-operated Ca²⁺ channels. This Ca²⁺ storage compartment is insensitive to mitochondrial uncouplers and appears diffusely distributed in the cell cytosol. The possibility is discussed that this low-affinity, high-capacity Ca²⁺ pool represents a previously unidentified subcompartment of the ER expressing a Tg-insensitive Ca²⁺–ATPase.     

Role of Inositol 1,4,5-Trishosphate Receptors in Pathogenesis of Huntington’s Disease and Spinocerebellar Ataxias

Huntington’s disease (HD) and spinocerebellar ataxias (SCAs) are autosomal-dominant neurodegenerative disorders. HD is caused by polyglutamine (polyQ) expansion in the amino-terminal region of a protein huntingtin (Htt) and primarily affects medium spiny striatal neurons (MSN). Many SCAs are caused by polyQ-expansion in ataxin proteins and primarily affect cerebellar Purkinje cells. The reasons for neuronal dysfunction and death in HD and SCAs remain poorly understood and no cure is available for the patients. Our laboratory discovered that mutant huntingtin, ataxin-2 and ataxin-3 proteins specifically bind to the carboxy-terminal region of the type 1 inositol 1,4,5-trisphosphate receptor (IP₃R1), an intracellular Ca²⁺ release channel. Moreover, we found that association of mutant huntingtin or ataxins with IP₃R1 causes sensitization of IP₃R1 to activation by IP₃ in planar lipid bilayers and in neuronal cells. These results suggested that deranged neuronal Ca²⁺ signaling might play an important role in pathogenesis of HD, SCA2 and SCA3. In support of this idea, we demonstrated a connection between abnormal Ca²⁺ signaling and neuronal cell death in experiments with HD, SCA2 and SCA3 transgenic mouse models. Additional data in the literature indicate that abnormal neuronal Ca²⁺ signaling may also play an important role in pathogenesis of SCAl, SCA5, SCA6, SCA14 and SCA15/16. Based on these results I propose that IP₃R and other Ca²⁺ signaling proteins should be considered as potential therapeutic targets for treatment of HD and SCAs.     

A Mathematical Model for Simultaneous Spatio-Temporal Dynamics of Calcium and Inositol 1,4,5-Trisphosphate in Madin–Darby Canine Kidney Epithelial Cells

The landmark paper by Hirose et al. (Hirose, K., Kadowaki, S., Tanabe, M., Takeshima, H., Iino, M., Science 284:1527–1530, 1999) presented experimental investigations to show that not only can calcium upregulate IP₃, but that it can also have an inhibitory effect on IP₃. In this paper, we present a preliminary model, which is consistent with these experiments. This model includes positive and negative feedback between calcium and IP₃ and is able to reproduce more precisely the data presented in Hirose et al. (Hirose, K., Kadowaki, S., Tanabe, M., Takeshima, H., Iino, M., Science 284:1527–1530, 1999). In the second part of the paper, the intracellular and intercellular calcium movement in Madin–Darby canine kidney epithelial cells is investigated. With the aid of the model we are able to identify the aspects of IP₃ and calcium signalling, which should be studied further experimentally before refining the model.     

Aluminum Inhibition of the Inositol 1,4,5-Trisphosphate Signal Transduction Pathway in Wheat Roots: A Role in Aluminum Toxicity?

In crop plants, aluminum (Al) rhizotoxicity is a major problem worldwide; however, the cause of Al toxicity remains elusive. The effects of Al on the inositol 1,4,5-trisphosphate (Ins[1,4,5]P3)-mediated signal transduction pathway were investigated in wheat roots. Exogenously applied Al (50 [mu]M) rapidly inhibited root growth (<2 hr) but did not affect general root metabolism. An Ins(1,4,5)P3 transient was generated in root tips, either before or after exposure to Al for 1 hr, by treating the roots with H2O2 (10 mM). Background (unstimulated) levels of Ins(1,4,5)P3 were similar in both Al-treated and Al-untreated root apices. However, H2O2-stimulated levels of Ins(1,4,5)P3 in root apices showed a significant (>50%) reduction after Al exposure in comparison with untreated controls, indicating that Al may be interfering with the phosphoinositide signaling pathway. When phospholipase C (PLC) was assayed directly in the presence of Al or other metal cations in microsomal membranes, AlCl3 and Al-citrate specifically inhibited PLC action in a dose-dependent manner and at physiologically relevant Al levels. Al exposure had no effect on inositol trisphosphate dephosphorylation or on a range of enzymes isolated from wheat roots, suggesting that Al exposure may specifically target PLC. Possible mechanisms of PLC inhibition by Al and the role of Ins(1,4,5)P3 in Al toxicity and growth are discussed. This study provides compelling evidence that the phytotoxic metal cation Al has an intracellular target site that may be integrally involved in root growth.     

Differential regulation of cell death programs in males and females by Poly (ADP-Ribose) Polymerase-1 and 17 β estradiol

Cell death can be divided into the anti-inflammatory process of apoptosis and the pro-inflammatory process of necrosis. Necrosis, as apoptosis, is a regulated form of cell death, and Poly-(ADP-Ribose) Polymerase-1 (PARP-1) and Receptor-Interacting Protein (RIP) 1/3 are major mediators. We previously showed that absence or inhibition of PARP-1 protects mice from nephritis, however only the male mice. We therefore hypothesized that there is an inherent difference in the cell death program between the sexes. We show here that in an immune-mediated nephritis model, female mice show increased apoptosis compared to male mice. Treatment of the male mice with estrogens induced apoptosis to levels similar to that in female mice and inhibited necrosis. Although PARP-1 was activated in both male and female mice, PARP-1 inhibition reduced necrosis only in the male mice. We also show that deletion of RIP-3 did not have a sex bias. We demonstrate here that male and female mice are prone to different types of cell death. Our data also suggest that estrogens and PARP-1 are two of the mediators of the sex-bias in cell death. We therefore propose that targeting cell death based on sex will lead to tailored and better treatments for each gender.     

Aromatic Prenylation in Phenazine Biosynthesis: DIHYDROPHENAZINE-1-CARBOXYLATE DIMETHYLALLYLTRANSFERASE FROM STREPTOMYCES ANULATUS*S?

The bacterium Streptomyces anulatus 9663, isolated from the intestine of different arthropods, produces prenylated derivatives of phenazine 1-carboxylic acid. From this organism, we have identified the prenyltransferase gene ppzP. ppzP resides in a gene cluster containing orthologs of all genes known to be involved in phenazine 1-carboxylic acid biosynthesis in Pseudomonas strains as well as genes for the six enzymes required to generate dimethylallyl diphosphate via the mevalonate pathway. This is the first complete gene cluster of a phenazine natural compound from streptomycetes. Heterologous expression of this cluster in Streptomyces coelicolor M512 resulted in the formation of prenylated derivatives of phenazine 1-carboxylic acid. After inactivation of ppzP, only nonprenylated phenazine 1-carboxylic acid was formed. Cloning, overexpression, and purification of PpzP resulted in a 37-kDa soluble protein, which was identified as a 5,10-dihydrophenazine 1-carboxylate dimethylallyltransferase, forming a C–C bond between C-1 of the isoprenoid substrate and C-9 of the aromatic substrate. In contrast to many other prenyltransferases, the reaction of PpzP is independent of the presence of magnesium or other divalent cations. The K_m value for dimethylallyl diphosphate was determined as 116 μm. For dihydro-PCA, half-maximal velocity was observed at 35 μm. K_cat was calculated as 0.435 s^-1. PpzP shows obvious sequence similarity to a recently discovered family of prenyltransferases with aromatic substrates, the ABBA prenyltransferases. The present finding extends the substrate range of this family, previously limited to phenolic compounds, to include also phenazine derivatives.The transfer of isoprenyl moieties to aromatic acceptor molecules gives rise to an astounding diversity of secondary metabolites in bacteria, fungi, and plants, including many compounds that are important in pharmacotherapy. However, surprisingly little biochemical and genetic data are available on the enzymes catalyzing the C-prenylation of aromatic substrates. Recently, a new family of aromatic prenyltransferases was discovered in streptomycetes (1), Gram-positive soil bacteria that are prolific producers of antibiotics and other biologically active compounds (2). The members of this enzyme family show a new type of protein fold with a unique α-β-β-α architecture (3) and were therefore termed ABBA prenyltransferases (1). Only 13 members of this family can be identified by sequence similarity searches in the data base at present, and only four of them have been investigated biochemically (3–6). Up to now, only phenolic compounds have been identified as aromatic substrates of ABBA prenyltransferases. We now report the discovery of a new member of the ABBA prenyltransferase family, catalyzing the transfer of a dimethylallyl moiety to C-9 of 5,10-dihydrophenazine 1-carboxylate (dihydro-PCA).² Streptomyces strains produce many of prenylated phenazines as natural products. For the first time, the present paper reports the identification of a prenyltransferase involved in their biosynthesis.Streptomyces anulatus 9663, isolated from the intestine of different arthropods, produces several prenylated phenazines, among them endophenazine A and B (Fig. 1A) (7). We wanted to investigate which type of prenyltransferase might catalyze the prenylation reaction in endophenazine biosynthesis. In streptomycetes and other microorganisms, genes involved in the biosynthesis of a secondary metabolite are nearly always clustered in a contiguous DNA region. Therefore, the prenyltransferase of endophenazine biosynthesis was expected to be localized in the vicinity of the genes for the biosynthesis of the phenazine core (i.e. of PCA).Open in a separate windowFIGURE 1.A, prenylated phenazines from S. anulatus 9663. B, biosynthetic gene cluster of endophenazine A.In Pseudomonas, an operon of seven genes named phzABCDEFG is responsible for the biosynthesis of PCA (8). The enzyme PhzC catalyzes the condensation of phosphoenolpyruvate and erythrose-4-phosphate (i.e. the first step of the shikimate pathway), and further enzymes of this pathway lead to the intermediate chorismate. PhzD and PhzE catalyze the conversion of chorismate to 2-amino-2-deoxyisochorismate and the subsequent conversion to 2,3-dihydro-3-hydroxyanthranilic acid, respectively. These reactions are well established biochemically. Fewer data are available about the following steps (i.e. dimerization of 2,3-dihydro-3-hydroxyanthranilic acid, several oxidation reactions, and a decarboxylation, ultimately leading to PCA via several instable intermediates). From Pseudomonas, experimental data on the role of PhzF and PhzA/B have been published (8, 9), whereas the role of PhzG is yet unclear. Surprisingly, the only gene cluster for phenazine biosynthesis described so far from streptomycetes (10) was found not to contain a phzF orthologue, raising the question of whether there may be differences in the biosynthesis of phenazines between Pseudomonas and Streptomyces.Screening of a genomic library of the endophenazine producer strain S. anulatus now allowed the identification of the first complete gene cluster of a prenylated phenazine, including the structural gene of dihydro-PCA dimethylallyltransferase.     

肌醇1,4,5-三磷酸受体与阿尔茨海默病

细胞内质网上的肌醇1,4,5-三磷酸受体(inositol 1,4,5-trisphosphate receptors, IP3Rs)是调节Ca~(2+)释放的重要离子通道。Ca~(2+)稳态是维持机体细胞生理功能的重要基础,Ca~(2+)信号参与酶激活、囊泡释放和细胞凋亡等多种细胞过程。研究表明,Ca~(2+)信号异常与阿尔茨海默病(Alzheimer's disease, AD)密切相关,神经元中钙信号异常可以导致细胞稳态失衡、突触功能丧失,甚至细胞死亡。现对IP3Rs的生物特性及其介导的Ca~(2+)释放在阿尔茨海默病发生发展过程中的作用进行综述。     

Synthesis of 3′-Amino-3′-deoxyguanosine 5′-Triphosphate

Abstract

Phosphorylation of 2′-0-acetyl-3′-trifluoroacetamido-3′-deoxy-N²-palmitoylguanosine with N-morpholino-O, O-bis(1-benzotriazolyl)phos-phate gives a 5′-phosphotriester. Removal of the benzotriazolyl group and addition of pyrophosphoric acid gave, after deblocking all protecting groups, GTP(3′NH₂).     

Epitope-tagged Receptor Knock-in Mice Reveal That Differential Desensitization of ��2-Adrenergic Responses Is because of Ligand-selective Internalization

Although ligand-selective regulation of G protein-coupled receptor-mediated signaling and trafficking are well documented, little is known about whether ligand-selective effects occur on endogenous receptors or whether such effects modify the signaling response in physiologically relevant cells. Using a gene targeting approach, we generated a knock-in mouse line, in which N-terminal hemagglutinin epitope-tagged α_2A-adrenergic receptor (AR) expression was driven by the endogenous mouse α_2AAR gene locus. Exploiting this mouse line, we evaluated α_2AAR trafficking and α_2AAR-mediated inhibition of Ca²⁺ currents in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment of hypertension, attention deficit and hyperactivity disorder, and enhancement of analgesia through actions on the α_2AAR subtype. We discovered a more rapid desensitization of Ca²⁺ current suppression by clonidine than guanfacine, which paralleled a more marked receptor phosphorylation and endocytosis of α_2AAR evoked by clonidine than by guanfacine. Clonidine-induced α_2AAR desensitization, but not receptor phosphorylation, was attenuated by blockade of endocytosis with concanavalin A, indicating a critical role for internalization of α_2AAR in desensitization to this ligand. Our data on endogenous receptor-mediated signaling and trafficking in native cells reveal not only differential regulation of G protein-coupled receptor endocytosis by different ligands, but also a differential contribution of receptor endocytosis to signaling desensitization. Taken together, our data suggest that these HA-α_2AAR knock-in mice will serve as an important model in developing ligands to favor endocytosis or nonendocytosis of receptors, depending on the target cell and pathophysiology being addressed.G protein-coupled receptors (GPCRs)⁴ represent the largest family of cell surface receptors mediating responses to hormones, cytokines, neurotransmitters, and therapeutic agents (1). In addition to regulating downstream signaling, ligand binding to a receptor can initiate phosphorylation of the active conformation of the receptor by G protein receptor kinases (GRKs) and subsequent binding of arrestins, thus restricting the magnitude and duration of the ligand-evoked signaling responses (2, 3). Binding of arrestins to GPCRs also leads to GPCR internalization (4, 5), a process that has been proposed as a means to desensitize receptor signaling at the cell surface, resensitize receptors, and/or initiate intracellular signaling (6, 7).Different ligands are able to induce distinct signaling and internalization profiles of the same receptor (8-14). However, the lack of available tools to study trafficking of endogenous GPCRs in native target cells has limited our understanding of ligand-selective endocytosis profiles and the relative contribution of receptor endocytosis to desensitization in native biological settings.To specifically test hypotheses regarding ligand-selective effects on GPCR internalization, and functional consequences of this trafficking on signaling, we utilized a homologous recombination gene targeting strategy to introduce a hemagglutinin (HA) epitope-tagged wild type α_2A-adrenergic receptor (AR) into the mouse ADRA2A gene locus (“knock-in”). The α_2AAR is a prototypical GPCR that couples to the G_i/o subfamily of G proteins (15). Studies on genetically engineered mice made null or mutant for the α_2AAR have revealed that this subtype mediates the therapeutic effects of α₂-adrenergic agents on blood pressure, pain perception, volatile anesthetic sparing, analgesia, and working memory enhancement (16-18). Two classic α₂-ligands, clonidine and guanfacine, have been widely used to treat hypertension (19), attention deficit and hyperactivity disorder (20), and to elicit analgesia (19, 21) mediated via the α_2AAR. Clinically guanfacine has a much longer duration of action than clonidine (22-24); this longer duration of action cannot be accounted for by the pharmacokinetic profile of these agents in human beings, as both drugs have a half-life of 12-14 h (25, 26). Because ligand-induced desensitization and trafficking of GPCRs have been implicated as critical mechanisms for modulating response duration in vivo (3), one hypothesis underlying the difference in duration between clonidine and guanfacine is that clonidine provokes accelerated desensitization of the α_2AAR via one or several mechanisms, whereas guanfacine does not. Signaling desensitization in response to these two agonists has not been compared under the same experimental settings. To specifically test this hypothesis, we have exploited our HA-α_2AAR knock-in mice so that we could examine these properties of guanfacine and clonidine in native target cells.We compared internalization of the α_2AAR and inhibition of Ca²⁺ currents induced by clonidine and guanfacine in primary superior cervical ganglia (SCG) neurons, where the α_2AAR is the major adrenergic receptor subtype controlling norepinephrine release and sympathetic tone (17, 27). Our data revealed a differential regulation of α_2AAR trafficking and signaling duration by clonidine versus guanfacine, i.e. clonidine induced a more dramatic desensitization of the α_2AAR than guanfacine, and this desensitization was largely because of α_2AAR internalization. These studies reveal the powerful tool that the HA-α_2AAR knock-in mice provide for identifying endocytosis-dependent and -independent physiological phenomena for this receptor subtype as a first step in defining novel loci for therapeutic intervention in the α_2AAR signaling/trafficking cascade.     

Construction of three new Gateway? expression plasmids for Trypanosoma cruzi

We present here three expression plasmids for Trypanosoma cruzi adapted to the Gateway^® recombination cloning system. Two of these plasmids were designed to express trypanosomal proteins fused to a double tag for tandem affinity purification (TAPtag). The TAPtag and Gateway^® cassette were introduced into an episomal (pTEX) and an integrative (pTREX) plasmid. Both plasmids were assayed by introducing green fluorescent protein (GFP) by recombination and the integrity of the double-tagged protein was determined by western blotting and immunofluorescence microscopy. The third Gateway adapted vector assayed was the inducible pTcINDEX. When tested with GFP, pTcINDEX-GW showed a good response to tetracycline, being less leaky than its precursor (pTcINDEX).     

Insulin Resistance in Striated Muscle-specific Integrin Receptor ��1-deficient Mice

Integrin receptor plays key roles in mediating both inside-out and outside-in signaling between cells and the extracellular matrix. We have observed that the tissue-specific loss of the integrin β1 subunit in striated muscle results in a near complete loss of integrin β1 subunit protein expression concomitant with a loss of talin and to a lesser extent, a reduction in F-actin content. Muscle-specific integrin β1-deficient mice had no significant difference in food intake, weight gain, fasting glucose, and insulin levels with their littermate controls. However, dynamic analysis of glucose homeostasis using euglycemichyperinsulinemic clamps demonstrated a 44 and 48% reduction of insulin-stimulated glucose infusion rate and glucose clearance, respectively. The whole body insulin resistance resulted from a specific inhibition of skeletal muscle glucose uptake and glycogen synthesis without any significant effect on the insulin suppression of hepatic glucose output or insulin-stimulated glucose uptake in adipose tissue. The reduction in skeletal muscle insulin responsiveness occurred without any change in GLUT4 protein expression levels but was associated with an impairment of the insulin-stimulated protein kinase B/Akt serine 473 phosphorylation but not threonine 308. The inhibition of insulin-stimulated serine 473 phosphorylation occurred concomitantly with a decrease in integrin-linked kinase expression but with no change in the mTOR·Rictor·LST8 complex (mTORC2). These data demonstrate an in vivo crucial role of integrin β1 signaling events in mediating cross-talk to that of insulin action.Integrin receptors are a large family of integral membrane proteins composed of a single α and β subunit assembled into a heterodimeric complex. There are 19 α and 8 β mammalian subunit isoforms that combine to form 25 distinct α,β heterodimeric receptors (1-5). These receptors play multiple critical roles in conveying extracellular signals to intracellular responses (outside-in signaling) as well as altering extracellular matrix interactions based upon intracellular changes (inside-out signaling). Despite the large overall number of integrin receptor complexes, skeletal muscle integrin receptors are limited to seven α subunit subtypes (α1, α3, α4, α5, α6, α7, and αν subunits), all associated with the β1 integrin subunit (6, 7).Several studies have suggested an important cross-talk between extracellular matrix and insulin signaling. For example, engagement of β1 subunit containing integrin receptors was observed to increase insulin-stimulated insulin receptor substrate (IRS)² phosphorylation, IRS-associated phosphatidylinositol 3-kinase, and activation of protein kinase B/Akt (8-11). Integrin receptor regulation of focal adhesion kinase was reported to modulate insulin stimulation of glycogen synthesis, glucose transport, and cytoskeleton organization in cultured hepatocytes and myoblasts (12, 13). Similarly, the integrin-linked kinase (ILK) was suggested to function as one of several potential upstream kinases that phosphorylate and activate Akt (14-18). In this regard small interfering RNA gene silencing of ILK in fibroblasts and conditional ILK gene knockouts in macrophages resulted in a near complete inhibition of insulin-stimulated Akt serine 473 (Ser-473) phosphorylation concomitant with an inhibition of Akt activity and phosphorylation of Akt downstream targets (19). However, a complex composed of mTOR·Rictor·LST8 (termed mTORC2) has been identified in several other studies as the Akt Ser-473 kinase (20, 21). In addition to Ser-473, Akt protein kinase activation also requires phosphorylation on threonine 308 Thr-30 by phosphoinositide-dependent protein kinase, PDK1 (22-24).In vivo, skeletal muscle is the primary tissue responsible for postprandial (insulin-stimulated) glucose disposal that results from the activation of signaling pathways leading to the translocation of the insulin-responsive glucose transporter, GLUT4, from intracellular sites to the cell surface membranes (25, 26). Dysregulation of any step of this process in skeletal muscle results in a state of insulin resistance, thereby predisposing an individual for the development of diabetes (27-33). Although studies described above have utilized a variety of tissue culture cell systems to address the potential involvement of integrin receptor signaling in insulin action, to date there has not been any investigation of integrin function on insulin action or glucose homeostasis in vivo. To address this issue, we have taken advantage of Cre-LoxP technology to inactivate the β1 integrin receptor subunit gene in striated muscle. We have observed that muscle creatine kinase-specific integrin β1 knock-out (MCKItgβ1 KO) mice display a reduction of insulin-stimulated glucose infusion rate and glucose clearance. The impairment of insulin-stimulated skeletal muscle glucose uptake and glycogen synthesis resulted from a decrease in Akt Ser-473 phosphorylation concomitant with a marked reduction in ILK expression. Together, these data demonstrate an important cross-talk between integrin receptor function and insulin action and suggests that ILK may function as an Akt Ser-473 kinase in skeletal muscle.